Development of SARS-CoV-2 antibody test technologies suitable for on-site diagnosis

This proposal aims to develop essential technologies for rapid and accurate SARS-CoV-2 antibody test in serum and droplet blood using microflow cytometry immunoassay (MCIA) for on-site testing. The test will assess levels of immunoglobin G (IgG) and immunoglobin M (IgM) antibodies produced in response to SARS-CoV-2 exposure. Unfortunately, none of the antibody testing tools currently […]

Read More